Advertisement

Topics

Latest "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" News Stories - Page: 2

09:43 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" found in our extensive news archives from over 250 global news sources.

More Information about Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 for you to read. Along with our medical data and news we also list Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018 Companies for you to search.

Showing "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" News Articles 26–50 of 36,000+

Monday 25th March 2019

InteRNA Appoints Andrea van Elsas, Ph.D. to Scientific Advisory Board

-- Co-inventor of original CTLA4-antibody and immuno-oncology innovator to expand the Company’s clinical development expertise -- InteRNA Technologies announced today the appointment of Andrea van Elsas, Ph.D., as a new member of the Company’s Scientific Advisory Board (SAB). Dr. van Elsas is an immuno-oncology expert with over 20 years of experien...


IONTAS named Small Business of the Year at Cambridge News Business Excellence Awards 2019

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019. Marking their 26th year, the Awards highlight Cambridge’s best business talent, with winners selected by a panel of experts encompassing a broad ra...

Evox Therapeutics Awarded £1.5 Million in Funding From Innovate UK

OXFORD, England, March 22, 2019 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has secured £1.5 million in funding from Innovate UK, the UK's Innovation Agency, through the Biomedical Catalyst Early Stage Award.


NeuroVive Pharmaceutical AB Publishes 2018 Annual Report

LUND, Sweden, 25 March 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now availabl...

Hauck & Aufhäuser belässt Gerresheimer auf 'Sell' - Ziel 50 Euro

Die Privatbank Hauck & Aufhäuser hat die Einstufung für Gerresheimer auf "Sell" mit einem Kursziel von 50 Euro belassen. Der Ausblick des Spezialverpackungsherstellers auf 2018/19 sei nichts ander...

Investments show UK biotech still booming despite Brexit

UK raised a quarter of all European biotech funds

FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder

Company announcement, Helsinki, 25 March 2019 at 9.00 am (EET)FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasi...

Synerkine Pharma Raises EUR3.3 Million in Series A Financing

Proceeds to build pipeline of novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain Synerkine Pharma B.V., which develops fusion proteins for the treatment of chronic pain, announced today that it successfully closed a EUR 3.3 million Series A financing from Thuja Capital, an undisclosed private investor, and the ...

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Featured in CannabisNewsAudio Publication on ...

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) Read more...

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall. Under the terms of the ag...

Botamedi KR announces groundbreaking Mannas(TM) 'Hydro-Network' technology, reduces risk of chronic diseases from tasty food

HONG KONG, March 25, 2019 /PRNewswire/ -- BotaMedi, a seasoned corporation in the biological research industry, is therefore targeting the food industry with the new introduction of Mannas™ and its patented 'Hydro-Network' technology, which is good news for the masses who want to enjoy good food but are also concerned about health issues. Mannas™ is a food additive that helps to control ...

ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in ...

MONTREAL, March 25, 2019 (GLOBE NEWSWIRE) Read more...

Harris Personal Injury Lawyers, Inc. Sues Wyndham Garden Ventura Pierpont Inn Following Slip and Fall Accident Resulting in Broken Neck

Harris Personal Injury Lawyers, Inc. represents woman who fell and broke her neck at the Wyndham Garden Ventura Pierpoint Inn; resulting in permanent disability. VENTURA, Calif. (PRWEB) March 25, 2019 Harris Personal Injury Lawyers, Inc. filed a complaint August 28, 2018 in Ventura County Superior Court against Wyndham Hotel Group, LLC and Wyndham Garden Ventura Pierpont Inn. The complaint is fil...

Inflazome Receives Funding from The Michael J. Fox Foundation for Parkinson’s Research

Funding in excess of US$1 million to support the development of a brain imaging probe for patient diagnosis and the clinical development of drugs to treat neurodegenerative diseases Inflazome is developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the NLRP3 inflammasome ...

Klinikartikel und Microscope

EUR 5,00 (0 Gebote)Angebotsende: Sonntag Mär-31-2019 19:32:47 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Klinikartikel und Microscope BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic software to … Continue reading →

REVA Receives Interim Funding Commitment and Announces Leadership Changes

SAN DIEGO, March 24, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that it has secured a letter of commitment for up to $3 million of debt financing to fund operations on an … Continue reading →

Antique Victorian Travelling Microscope By Baker (london).

82,02 EUR (0 Pujas)Fecha de finalización: lunes mar-25-2019 13:22:37 CETPujar ahora | Añadir a lista de seguimiento Biotech365 : Antique Victorian Travelling Microscope By Baker (london). BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

PracticeLink Magazine to Sponsor PracticeLink Live! Dallas – a Free Physician Career Fair March 28, 2019

DALLAS (PRWEB) March 25, 2019 According to ACGME, the state of Texas has the third-largest number of residents with more than 7,207 residents and 1,754 fellows for the 2018-2019 academic year. The 290 specialty programs and 403 subspecialty programs rank Texas third-largest in the nation. Dal...

Historischer Reichert Metall Mikroskop Katalog 1926 / microscope book

EUR 42,00Angebotsende: Mittwoch Apr-10-2019 13:15:32 CESTSofort-Kaufen für nur: EUR 42,00Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Historischer Reichert Metall Mikroskop Katalog 1926 / microscope book BioMarketplace You want to propose your products or a Biotech Company, a … Continue reading →

Foldscope Kit – Pocket Mikroskop Kit – Origami Microscope

EUR 17,10Angebotsende: Montag Apr-22-2019 13:43:19 CESTSofort-Kaufen für nur: EUR 17,10Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Foldscope Kit – Pocket Mikroskop Kit – Origami Microscope BioMarketplace You want to propose your products or a Biotech Company, a … Continue reading →

Sunday 24th March 2019

Agilent E4402 Spectrum Analyzer

EUR 201,50 (31 Gebote)Angebotsende: Sonntag Mär-31-2019 17:30:05 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Agilent E4402 Spectrum Analyzer BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic software … Continue reading →

ideaPoint Announces Integration of Clarivate Analytics’ Cortellis for Enhanced Competitive Insight

BOSTON, March 25, 2019 (GLOBE NEWSWIRE) Read more...

Perkin Elmer Lambda 35 UV/VIS Spectrophotometer

$99.00 (1 Bid)End Date: Friday Mar-29-2019 13:06:35 PDTBid now | Add to watch list Biotech365 : Perkin Elmer Lambda 35 UV/VIS Spectrophotometer BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic software … Continue reading →

BioStem Technologies, Inc. Announces Corporate Update

Pompano Beach, FL, March 25, 2019 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), today provided a corporate update to the Company’s continuing growth strategy. In January of 2019, BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc., finalized the transition of its operations to the Companies’ Pompano Beach f...

Pain Therapeutics Reports 2018 Financial Results and Corporate Update

AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported financial results for the year ended December 31, 2018. Net loss in 2018 was $6.6 million, or $0.61 per share, compared to a net loss in 2017 of $11.9 million, or $1.82 per share. Cash used in operations during the year ended December 31, 2018 was $4.8 million. Cash and cash equivalents were ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks